Guy Jerusalem

Guy Jerusalem

UNVERIFIED PROFILE

Are you Guy Jerusalem?   Register this Author

Register author
Guy Jerusalem

Guy Jerusalem

Publications by authors named "Guy Jerusalem"

Are you Guy Jerusalem?   Register this Author

99Publications

2441Reads

33Profile Views

HER2+ breast cancer treatment and cardiotoxicity: monitoring and management.

Breast Cancer Res Treat 2019 Jun 5. Epub 2019 Jun 5.

Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05303-yDOI Listing
June 2019

Real-world use of granulocyte colony-stimulating factor in ambulatory breast cancer patients: a cross-sectional study.

Support Care Cancer 2019 Mar 11;27(3):1099-1108. Epub 2018 Aug 11.

Gent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4399-3DOI Listing
March 2019

Neutropenia management in patients receiving myelosuppressive polychemotherapy for early breast cancer in Belgium: BRONS study results.

Acta Clin Belg 2019 Jan 4:1-8. Epub 2019 Jan 4.

a Department of Medical Oncology, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), Institut Roi Albert II , Université catholique de Louvain , Brussels , Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17843286.2018.1563735DOI Listing
January 2019

Exercise and Education Program After Breast Cancer: Benefits on Quality of Life and Symptoms at 3, 6, 12, and 24 Months' Follow-up.

Clin Breast Cancer 2018 10 19;18(5):e1189-e1204. Epub 2018 May 19.

Department of Sport and Rehabilitation Science, Liège University, Liège, Belgium; Department of Physical and Rehabilitation Medicine, Liège University Hospital, Liège, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2018.05.004DOI Listing
October 2018

Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3.

J Clin Oncol 2018 Aug 3;36(24):2465-2472. Epub 2018 Jun 3.

Dennis J. Slamon, University of California Los Angeles Medical Center, Santa Monica, CA; Patrick Neven, Multidisciplinary Breast Centre, Universitair Ziekenhuis, Leuven; Guy Jerusalem, Centre Hospitalier Universitaire de Liege and Liege University, Liège, Belgium; Stephen Chia, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Peter A. Fasching, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen; Arnd Nusch, Practice for Hematology and Internal Oncology, Velbert, Germany; Michelino De Laurentiis, Istituto Nazionale Tumori "Fondazione G. Pascale," Naples; Giulia Val Bianchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy; Seock-Ah Im, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea; Katarina Petrakova, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Francisco J. Esteva, New York University Langone Health, New York, NY; Miguel Martín, Instituto de Investigacion Sanitaria Gregorio Marañon, Centro de Investigación Biomédica en Red de Cáncer, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid; Luis De la Cruz-Merino, Hospital Universitario Virgen Macarena, Seville, Spain; Gabe S. Sonke, Netherlands Cancer Institute/Borstkanker Onderzoek Groep Study Center, Amsterdam, the Netherlands; J. Thaddeus Beck, Highlands Oncology Group, Fayetteville, AR; Xavier Pivot, Institut Régional du Cancer, Strasbourg, France; Gena Vidam, Karen Rodriguez Lorenc, Michelle Miller, and Tetiana Taran, Novartis Pharmaceuticals, East Hanover, NJ; and Yingbo Wang, Novartis Pharma, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.9909
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.9909DOI Listing
August 2018

First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study.

Breast 2018 Apr 8;38:144-149. Epub 2018 Jan 8.

Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CiberOnc, GEICAM, Madrid 28007, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2017.12.016DOI Listing
April 2018

Natural Antisense Transcripts: Molecular Mechanisms and Implications in Breast Cancers.

Int J Mol Sci 2018 Jan 2;19(1). Epub 2018 Jan 2.

Department of Medical Oncology, University Hospital (CHU), 4500 Liège, Belgium.

View Article

Download full-text PDF

Source
http://www.mdpi.com/1422-0067/19/1/123
Publisher Site
http://dx.doi.org/10.3390/ijms19010123DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796072PMC
January 2018

Association between self-perception of aging, view of cancer and health of older patients in oncology: a one-year longitudinal study.

BMC Cancer 2017 Sep 2;17(1):614. Epub 2017 Sep 2.

Psychology of Aging Unit, Department of Psychology, University of Liège (ULg), Traverse des Architectes (B63c), 4000, Liege, BE, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3607-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581442PMC
September 2017

MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib.

Br J Cancer 2017 Mar 14;116(6):742-751. Epub 2017 Feb 14.

Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer (GIGA-Cancer), University of Liège, Liège 4000, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.23DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355928PMC
March 2017

Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast Cancer.

Breast Cancer (Auckl) 2016 4;10:239-252. Epub 2017 Jan 4.

Medical Oncology, CHU Sart Tilman Liege, Liege, Belgium.; Liege University, Liege, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/BCBCR.S12443DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214808PMC
January 2017

Multidisciplinary management of breast cancer.

Arch Public Health 2016 5;74:50. Epub 2016 Dec 5.

Department of Sports and Rehabilitation Sciences, Liège University, Allée des Sports 4 - B21, 4000 Liège, Belgium ; Department of Physical Medicine, Liège University Hospital, Avenue de l'Hôpital 1 - CHU B35, 4000 Liège, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13690-016-0163-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137213PMC
December 2016

The European Association of Cardiovascular Imaging/Heart Failure Association Cardiac Oncology Toxicity Registry: long-term benefits for breast cancer treatment.

Future Oncol 2015 7;11(20):2791-4. Epub 2015 Sep 7.

University of Liège Hospital, GIGA Cardiovascular Sciences, Cardio-Oncology Clinic Unit, CHU Sart Tilman Liege & Liege University, Domaine Universitaire du Sart Tilman, B35, 4000 Liege, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.15.227DOI Listing
August 2016

Molecular Alterations and Everolimus Efficacy in Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Biomarker Analysis From BOLERO-1 and BOLERO-3.

J Clin Oncol 2016 06 18;34(18):2115-24. Epub 2016 Apr 18.

Fabrice André, Institut Gustav Roussy, INSERM Unit U981, Université Paris Sud, Villejuif, France; Sara Hurvitz and Dennis Slamon, University of California, Los Angeles, Los Angeles, CA; Angelica Fasolo, San Raffaele Scientific Institute, Milan, Italy; Ling-Ming Tseng, National Yang Ming University, Taipei, Taiwan; Guy Jerusalem, University of Liège, Liege, Belgium; Sharon Wilks, Cancer Care Center of South Texas, San Antonio, TX; Ruth O'Regan, University of Wisconsin Carbone Cancer Center, Madison, WI; Claudine Isaacs, Georgetown University, Washington DC; Masakazu Toi, Kyoto University, Sakyo-ku, Kyoto, Japan; Howard Burris, Sarah Cannon Research Institute, Nashville, TN; Wei He, Douglas Robinson, and Markus Riester, Novartis Institutes for BioMedical Research, Cambridge, MA; and Tetiana Taran and David Chen, Novartis Pharmaceuticals Corporation, East Hanover, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.9161DOI Listing
June 2016

Triple-negative breast cancer: treatment challenges and solutions.

Breast Cancer (Dove Med Press) 2016 20;8:93-107. Epub 2016 May 20.

Medical Oncology Department, CHU Sart Tilman Liege, Domaine Universitaire du Sart Tilman, Liege, Belgium; University of Liege, Liege, Belgium.

View Article

Download full-text PDF

Source
https://orbi.ulg.ac.be/bitstream/2268/198893/1/Triple-negati
Web Search
https://www.dovepress.com/triple-negative-breast-cancer-trea
Publisher Site
http://dx.doi.org/10.2147/BCTT.S69488DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881925PMC
June 2016

Predicting Reversibility of Anticancer Drugs-Related Cardiac Dysfunction: A New Piece to the Routine Use of Deformation Imaging.

Echocardiography 2016 Apr;33(4):504-9

Medical Oncology, CHU Sart Tilman Liege and Liege University, University Sart Tilman, Liege, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/echo.13187DOI Listing
April 2016

Chemotherapy options for patients suffering from heavily pretreated metastatic breast cancer.

Future Oncol 2015 ;11(12):1775-89

Medical Oncology CHU Sart Tilman Liege, Domaine Universitaire du Sart Tilman, B35, 4000 Liege, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.15.80DOI Listing
March 2016

Corrigendum to "Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicenter prospective study" [J. Geriatr. Oncol. 6 (2015) 401-410].

J Geriatr Oncol 2016 Mar 8;7(2):142-3. Epub 2016 Feb 8.

Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium; Department of Oncology, KU Leuven, Leuven, Belgium. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2016.01.005DOI Listing
March 2016

Ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads.

Clin Interv Aging 2015 31;10:117-25. Epub 2014 Dec 31.

University of Liège, Psychology of Aging Unit, Liège, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CIA.S70942DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317143PMC
September 2015

Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicentre prospective study.

J Geriatr Oncol 2015 Sep 18;6(5):401-10. Epub 2015 Aug 18.

Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium; Department of Oncology, KU Leuven, Leuven, Belgium. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2015.07.005DOI Listing
September 2015

BRCA1 germline mutation and glioblastoma development: report of cases.

BMC Cancer 2015 Mar 26;15:181. Epub 2015 Mar 26.

University of Liège, GIGA-Cancer Research, Human Genetics Unit, Liège, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1205-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377178PMC
March 2015

Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 Expression.

J Cell Physiol 2015 Feb;230(2):473-81

University of Liège, Laboratory of Medical Oncology, Liège, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.24730DOI Listing
February 2015

A new era of improving progression-free survival with dual blockade in postmenopausal HR(+), HER2(-) advanced breast cancer.

Cancer Treat Rev 2015 Feb 30;41(2):94-104. Epub 2014 Dec 30.

Royal Melbourne Hospital, Grattan St., Parkville, Melbourne 3050, Australia. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03057372140021
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2014.12.011DOI Listing
February 2015

The association of chemotherapy versus hormonal therapy and health outcomes among patients with hormone receptor-positive, HER2-negative metastatic breast cancer: experience from the patient perspective.

Expert Rev Pharmacoecon Outcomes Res 2014 Dec 18;14(6):929-40. Epub 2014 Aug 18.

Kantar Health, Health Outcomes Practice, 1 Independence Way, Suite 220, Princeton, NJ 08540, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.2014.949243DOI Listing
December 2014

EGFR activation and signaling in cancer cells are enhanced by the membrane-bound metalloprotease MT4-MMP.

Cancer Res 2014 Dec 15;74(23):6758-70. Epub 2014 Oct 15.

Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliquée-Cancer (GIGA-Cancer), University of Liège, Liège, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-2994DOI Listing
December 2014

Multicenter implementation of geriatric assessment in Belgian patients with cancer: a survey on treating physicians' general experiences and expectations.

J Geriatr Oncol 2014 Oct 29;5(4):431-8. Epub 2014 Jun 29.

Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium; Department of Oncology, KU Leuven, Leuven, Belgium. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2014.06.043DOI Listing
October 2014

A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease.

Breast Cancer Res Treat 2014 Jun 13;145(2):411-8. Epub 2014 Apr 13.

Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield Cancer Research Centre, Sheffield, S10 2SJ, England, UK,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2939-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025174PMC
June 2014

Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes.

Breast Cancer (Dove Med Press) 2014 17;6:43-57. Epub 2014 Apr 17.

Medical Oncology, CHU Sart Tilman Liege, Domaine Universitaire du Sart Tilman, Liege, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BCTT.S38679DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000187PMC
June 2014

[Impact of double stigmatization in oncogeriatry: reviewing existing data].

Geriatr Psychol Neuropsychiatr Vieil 2014 Jun;12(2):131-8

Unité de psychologie de la sénescence, Université de Liège, Belgique.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/pnv.2014.0471DOI Listing
June 2014

Phase Ib study of Buparlisib plus Trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on Trastuzumab-based therapy.

Clin Cancer Res 2014 Apr 27;20(7):1935-45. Epub 2014 Jan 27.

Authors' Affiliations: Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Catalan Institute of Oncology, Barcelona, Spain; Sarah Cannon Research Institute, Nashville, Tennessee; Novartis Pharmaceuticals, East Hanover, NJ; Novartis Pharmaceuticals, Florham Park, New Jersy; C.H.U. Sart-Tilman, Liege; Oncologisch Centrum AZ-St. Augustinus Oncology, Antwerp, Belgium; Novartis Pharma AG, Basel, Switzerland; Novartis Oncology, Paris, France; Memorial Sloan-Kettering Cancer Centre, New York, New York; Highlands Oncology Group, Fayetteville, Arkansas; and Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1070DOI Listing
April 2014

Final overall survival: fulvestrant 500 mg vs 250 mg in the randomized CONFIRM trial.

J Natl Cancer Inst 2014 Jan 7;106(1):djt337. Epub 2013 Dec 7.

Affiliations of authors: "Sandra Pitigliani" Medical Oncology Unit, Hospital of Prato, Prato, Italy (ADL, LM); Medical Oncology, Centre Hospitalier Universitaire Sart Tilman and Liège University, Liège, Belgium (GJ); Department of Oncology, First Faculty of Medicine of Charles University, Prague, Czech Republic (LP); Clinical Oncology, Instituto Nacional del Cáncer, Santiago, Chile (RT); Dnipropetrovsk Municipal Clinical Hospital, Dnipropetrovsk, Ukraine (INB); Republican Clinical Oncological Center, Kazan, Russia (RK); AZ Klina, Brasschaat, Belgium (DV); Mastology, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil (JLP); Thoracal Department, Medical Radiological Science Center, Obninsk, Russia (IS); Chemotherapy and Combined Therapy, Russian Cancer Research Centre, Moscow, Russia (MRL); Medical Oncology, Kansas City Cancer Center, Kansas City, MO USA (KP); AstraZeneca Pharmaceuticals, Macclesfield, UK (SG, YR); Medical Oncology Service, Instituto de Investigacion Sanitaria, Hospital Universitario Gregorio Maranon, Universidad Complutense, Madrid, Spain (MM).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt337DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906991PMC
January 2014

mTOR inhibitors in advanced breast cancer: ready for prime time?

Cancer Treat Rev 2013 Nov 1;39(7):742-52. Epub 2013 Apr 1.

Breakthrough Breast Cancer Centre, Institute of Cancer Research, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2013.02.005DOI Listing
November 2013

[Positron emission tomography in oncology: an update].

Rev Prat 2007 Nov;57(17):1864-70

Service d'Oncologie médicale, départment de médecine, Université de Liège, Belgique.

View Article

Download full-text PDF

Source
November 2007

Sequential positron emission tomography using [18F]fluorodeoxyglucose for monitoring response to chemotherapy in metastatic breast cancer.

Clin Cancer Res 2006 Nov;12(21):6437-43

Division of Nuclear Medicine, Hôtel Dieu and Division of Biostatistics, Hôpital St. Jacques, CHU Nantes, France; and Divisions of Medical Oncology and Nuclear Medicine, CHU Liège, University of Liège, Liège, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-0383DOI Listing
November 2006

Positron emission tomography imaging for lymphoma.

Curr Opin Oncol 2005 Sep;17(5):441-5

Division of Hemato-Oncology, Department of Medicine, Medical Oncology CHU, University of Liège, Sart Tilman B35, B-4000 Liège, Belgium.

View Article

Download full-text PDF

Source
September 2005

Evaluation of therapy for lymphoma.

Semin Nucl Med 2005 Jul;35(3):186-96

Division of Medical Oncology, Department of Medicine, University of Liège, CHU Sart Tillman B35, B-4000 Liège 1, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2005.02.004DOI Listing
July 2005

Metabolic monitoring of chemosensitivity with 18FDG PET.

Methods Mol Med 2005 ;111:417-40

Department of Hematology/Oncology, University Hospital of Liège, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/1-59259-889-7:417DOI Listing
June 2005

18F-FDG PET in children with lymphomas.

Eur J Nucl Med Mol Imaging 2005 Jan 24;32(1):31-8. Epub 2004 Jul 24.

Division of Nuclear Medicine, University Hospital, Liège, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-004-1604-zDOI Listing
January 2005

[Positron emission tomography: a revolution in oncology?].

Rev Prat 2003 Oct;53(15):1629-30

Service d'oncologie médicale, université de Liège, Liège, Belgique.

View Article

Download full-text PDF

Source
October 2003

Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.

J Nucl Med 2003 Apr;44(4):533-9

Division of Nuclear Medicine, University Hospital/CHU de Sart Tilman, 4000 Liège 1, Belgium.

View Article

Download full-text PDF

Source
April 2003

Does positron emission tomogrpahy have a role in routine clinical practice in patients with Hodgkin's disease?

Clin Lymphoma 2002 Sep;3(2):125-6

Department of Medicine, Division of Oncology-Hematology, University of Liège, Liège, Belgium.

View Article

Download full-text PDF

Source
September 2002

Commentary on "Noninvasive detection of multidrug resistance in patients with hematological malignancies: are we there yet?".

Clin Lymphoma 2002 Mar;2(4):249

Department of Medicine, Division of Onco-Hematology, University of Liège, Belgium.

View Article

Download full-text PDF

Source
March 2002